Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer Centers

Summary

This is a randomized, multicenter, prospective, phase III study conducted in daily emergency rooms of French Regional Comprehensive Cancer Centers. In the standard arm, patients will be managed regardless of their PALLIA-10 score, following conventional strategy. In the experimental arm, patients will be systematically referred to a palliative care team.

Eligibility

Inclusion Criteria:

* Male or female ≥ 18 years at the day of consenting to the study;
* Confirmed diagnosis of any type of solid or haematology tumours, with or without Current oncological treatment, such as chemotherapy, immunotherapy, targeted therapy, etc;
* Unscheduled admission in a French Regional Comprehensive Anti-Cancer Centre due to an acute, unpredictable, intercurrent event related to cancer, its therapies or a comorbidity;
* Patient for whom disease is considered as not curable;
* PALLIA-10 Score \> 3/10;
* Willingness and ability to comply with the study requirements;
* Signed and dated informed consent indicating that the patient has been informed of all the aspects of the trial prior to enrolment;
* Patient must be covered by a medical insurance.

Exclusion Criteria:

* Patient without consciousness, unable to provide a written informed consent (context of emergency);
* Patient treated with a curative intent;
* Previous randomization in this clinical study;
* Patients already followed-up by a palliative care team;
* Life expectancy shorter than 1 month, as per the emergency units' staff judgement.
* Any medical or psychosocial condition that would compromise the patient's compliance to the study visits or would likely interfere with the completion of Patient-Reported Outcomes.
* Patients under tutorship or curatorship.

Conditions2

Browse More Trials